Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

Collaboration

The age of collaboration: why pharma companies now have to work together

December 9, 2015 Research and Development R&D, co-operation, collaboration, pharma

It seems 2015 may be remembered as the year of the mega merger; the year when all records were broken …
Feature
Gilead sign

Gilead awaits EU decision on hep C combo treatment

December 8, 2015 Research and Development EMA, Gilead, SOF/VEL, accelerated assessment, hepatitis C, sovaldi, velpatasvir

The EMA has granted Gilead Sciences an accelerated assessment for its application for a new Sovaldi combination treatment.The combination contains …
News
Red blood cells

ASH 2015 roundup: Amgen, MorphoSys, Novartis and Roche present new trial data

December 8, 2015 Research and Development Amgen, Cancer, Novartis, Roche, ash, morphosys, oncology

Amgen Amgen presented data from three Phase II trials evaluating Blincyto (blinatumomab) in acute lymphoblastic leukemia (ALL)- a rare and …
News
janssen_latest_logo_on_sign_closer

Strong cancer trial data for Janssen at ASH 2015

December 8, 2015 Research and Development Cancer, Janssen, darzalex, imbruvica, oncology

Janssen presented new cancer trial data at the 57th Annual American Society of Haematology (ASH) meeting Orlando, Florida – with …
News
Ninlaro

Takeda’s Ninlaro extends myeloma survival in trial

December 7, 2015 Manufacturing and Production, Research and Development Ninlaro, Takeda, ash, ixazomib, multiple myeloma

Takeda has presented trial data showing that treatment with its oral proteasome inhibitor Ninlaro extended progression free survival by 35% …
News
eczema_finger

Featured Market Report: Atopic Dermatitis (eczema) Forecast in 17 Major Markets

December 7, 2015 Manufacturing and Production, Research and Development Black Swan, eczema

Featured Market Report: Forecast Report on Atopic Dermatitis (eczema) in 17 Major Markets  Black Swan’s report on Atopic Dermatitis, also …
Feature
Pfizer CEO Ian Read

Five benefits and challenges of the Pfizer/Allergan mega-merger

December 7, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Pfizer, acquisitions, mergers, takeovers

Pfizer was extremely keen to get the $160 billion deal done, but what is it getting out of the acquisition, …
Feature
Merck image

Late-stage failure for Merck and Threshold cancer drug

December 7, 2015 Research and Development, Sales and Marketing Merck, Pancreatic cancer, Threshold Pharmaceuticals, evofosfamide, late-stage failure, phase III, sarcoma

Merck and its development partner Threshold Pharmaceuticals say they will not pursue regulatory approval for evofosfamide in advanced soft tissue …
News

Takeda reveals five-year Adcetris survival data

December 6, 2015 Research and Development, Sales and Marketing Hodgkin lymphoma, Takeda, oncology

Takeda UK has announced post-treatment follow up data from the pivotal Phase II study of Adcetris revealing a five-year survival …
News
kyprolis_amgen

Amgen’s Kyprolis doubles Velcade benefit in head-to-head study

December 5, 2015 Research and Development, Sales and Marketing Amgen, Cancer, Kyprolis, Takeda, Velcade, multiple myeloma

Amgen has announced that its multiple myeloma therapy Kyprolis displayed superiority to Takeda’s Velcade in the Phase III ENDEAVOR study …
News
Neusentis

Pfizer to close UK R&D site in surprise move

December 4, 2015 Research and Development, Sales and Marketing Pfizer

Two weeks after its $160 billion buyout of botox-maker Allergan, Pfizer has announced that it is to close a UK …
News
alzheimers-oct-15-portraits-039

Chief scientific officers appointed at dementia Drug Discovery Alliance

December 3, 2015 Medical Communications, Research and Development Alzheimer's Research, dementia, dementia drug discovery alliance

Alzheimer’s Research UK has appointed three chief scientific officers to drive its £30million Drug Discovery Alliance. The Alliance, which unites …
Appointment
Alkermes' Richard Pops

Alkermes aims to take the next biotech step

December 3, 2015 Medical Communications, Research and Development Alkermes

“We think we can be the next Biogen, or a Celgene or a Vertex – we have that much firepower …
Feature

NICE turns down bone disorder drug for NHS

December 3, 2015 Research and Development Alexion, NICE, Strensiq

NICE has published draft guidance as part of its highly specialised technologies programme, not recommending Alexion Pharma’s Strensiq (asfotase alfa) …
News
Propeller Health smart inhaler

GSK collaborates on ‘smart inhaler’ technology for respiratory trials

December 3, 2015 Research and Development COPD, GSK, Propeller, Propeller Health, asthma, clinical trials, ellipta, inhalers, smart drugs, smart inhalers

GSK has entered the ‘smart drug’ industry by partnering with a health technology company to develop a sensor for use …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026